Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 USD | 0.00% | -2.62% | +74.22% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 146M |
---|---|---|---|---|---|
Net income 2024 * | -34M | Net income 2025 * | -48M | EV / Sales 2024 * | - |
Net cash position 2024 * | 80.2M | Net cash position 2025 * | 40.65M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.62
x | P/E ratio 2025 * |
-2.99
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on Regulus Therapeutics Inc.
1 week | -2.62% | ||
Current month | -2.62% | ||
3 months | +57.04% | ||
6 months | +55.31% | ||
Current year | +74.22% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 16-01-03 |
Preston Klassen
PSD | President | 55 | 23-06-21 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 19-08-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 17-05-31 |
David Baltimore
BRD | Director/Board Member | 86 | 08-12-31 |
Director/Board Member | 75 | 13-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.23 | 0.00% | 209,601 |
24-06-06 | 2.23 | -5.91% | 311,366 |
24-06-05 | 2.37 | +7.24% | 289,238 |
24-06-04 | 2.21 | 0.00% | 318,983 |
24-06-03 | 2.21 | -3.49% | 473,820 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.22% | 146M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- RGLS Stock